These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 1159829)

  • 1. The attacker: target-cell ratio and serum effects on in vitro cell-mediated immunity.
    Mantovani A; Veechi A; Spreafico F
    J Natl Cancer Inst; 1975 Aug; 55(2):483-4. PubMed ID: 1159829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural cytotoxicity against mouse hepatitis virus-infected target cells. I. Correlation of cytotoxicity with virus binding to leukocytes.
    Holmes KV; Welsh RM; Haspel MV
    J Immunol; 1986 Feb; 136(4):1446-53. PubMed ID: 3003198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-mediated immunity to Friend virus-induced leukemia. I. Modification of 125IUdR release cytotoxicity assay for use with suspension target cells.
    Ting C-C ; Bushar GS; Rodrigues D; Herberman RB
    J Immunol; 1975 Nov; 115(5):1351-6. PubMed ID: 170343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Participation of T-lymphocytes in the curative effect of a novel synthetic polyamine analogue, N,N'-bis[3-(ethylamino)propyl]-1,7-heptanediamine, against L1210 leukemia in vivo.
    Bowlin TL; Prakash NJ; Edwards ML; Sjoerdsma A
    Cancer Res; 1991 Jan; 51(1):62-6. PubMed ID: 1988107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acceleration of allogeneic antitumor immunity with immune RNA in vitro and T-cell suppression by L1210 tumor bearer spleen cells.
    Miura T; Maekawa T; Kurashige S; Mitsuhashi S
    Cancer Res; 1981 Feb; 41(2):383-98. PubMed ID: 6160907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification and target cell range of in vivo elicited blast natural killer cells.
    Biron CA; Pedersen KF; Welsh RM
    J Immunol; 1986 Jul; 137(2):463-71. PubMed ID: 3722814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization of BALB/c mice with recombinant simian virus 40 large tumor antigen induces antibody-dependent cell-mediated cytotoxicity against simian virus 40-transformed cells. An antibody-based mechanism for tumor immunity.
    Bright RK; Shearer MH; Kennedy RC
    J Immunol; 1994 Sep; 153(5):2064-71. PubMed ID: 8051411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-mediated cytotoxicity results from, but may not be critical for, primary allograft rejection.
    Walsh CM; Hayashi F; Saffran DC; Ju ST; Berke G; Clark WR
    J Immunol; 1996 Feb; 156(4):1436-41. PubMed ID: 8568245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of high-grade tumor-specific immunity in a host using a cytotoxic T-lymphocyte clone specific for a stable tumor antigen on murine leukemia L1210.
    Rahman SM; Kawashima K; Nakashima I; Nagase F
    Cancer Res; 1988 Nov; 48(22):6450-4. PubMed ID: 3263189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytophilic antibody as an auxiliary factor in cell-mediated immunity.
    Ptak W
    Allerg Immunol (Leipz); 1973; 19(2-4):290-6. PubMed ID: 4375939
    [No Abstract]   [Full Text] [Related]  

  • 11. Increased sensitivity to MHC-nonrestricted lysis of BL6 melanoma cells by transfection with class I H-2Kb gene.
    Gorelik E; Jay G; Kwiatkowski B; Herberman RB
    J Immunol; 1990 Sep; 145(5):1621-32. PubMed ID: 2384672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IFN-gamma differentially modulates the susceptibility of L1210 and P815 tumor targets for macrophage-mediated cytotoxicity. Role of macrophage-target interaction coupled to nitric oxide generation, but independent of tumor necrosis factor production.
    Leu RW; Leu NR; Shannon BJ; Fast DJ
    J Immunol; 1991 Sep; 147(6):1816-22. PubMed ID: 1909732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage.
    Colotta F; Peri G; Villa A; Mantovani A
    J Immunol; 1984 Feb; 132(2):936-44. PubMed ID: 6690624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the induction and expression of T cell-mediated immunity. XIV. Antigen-nonspecific oxidation-dependent cellular cytotoxicity (ODCC) mediated by sodium periodate oxidation of cytotoxic T lymphocytes.
    Fan J; Bonavida B
    J Immunol; 1983 Sep; 131(3):1426-32. PubMed ID: 6193189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of 2,7-bis(2-diethylamino)ethoxy)fluoren-9-one dihydrochloride (Tilorone) upon cell-mediated immunity in mice.
    Friedlaender GE; Mosher MB; Mitchell MS
    Cancer Res; 1974 Feb; 34(2):304-7. PubMed ID: 4544018
    [No Abstract]   [Full Text] [Related]  

  • 16. Heterologous sera: a target for in vitro cell-mediated cytotoxicity.
    Forni G; Green I
    J Immunol; 1976 Jun; 116(6):1561-5. PubMed ID: 178800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative in vitro studies on effector cell diversity in the cellular immune response to murine sarcoma virus (MSV)-induced tumors in mice.
    Plata F; Gomard E; Leclerc JC; Levy JP
    J Immunol; 1974 Apr; 112(4):1477-87. PubMed ID: 4360862
    [No Abstract]   [Full Text] [Related]  

  • 18. Modulation of cell-mediated cytotoxicity function after alteration of fatty acid composition in vitro.
    Bialick R; Gill R; Berke G; Clark WR
    J Immunol; 1984 Jan; 132(1):81-7. PubMed ID: 6197462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA vaccination against the idiotype of a murine B cell lymphoma: mechanism of tumor protection.
    Syrengelas AD; Levy R
    J Immunol; 1999 Apr; 162(8):4790-5. PubMed ID: 10202021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of potent immunoglobulins by group A streptococcus for antibody dependent cell-mediated cytotoxicity in mice.
    Murayama T; Koshimura S; Natsuume-Sakai S
    Jpn J Exp Med; 1985 Dec; 55(6):225-32. PubMed ID: 3915030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.